Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Dec 23;94(26):14736-41.
doi: 10.1073/pnas.94.26.14736.

alpha+-Thalassemia protects children against disease caused by other infections as well as malaria

Affiliations

alpha+-Thalassemia protects children against disease caused by other infections as well as malaria

S J Allen et al. Proc Natl Acad Sci U S A. .

Abstract

In the South West Pacific region, the striking geographical correlation between the frequency of alpha+-thalassemia and the endemicity of Plasmodium falciparum suggests that this hemoglobinopathy provides a selective advantage against malaria. In Vanuatu, paradoxically, alpha+-thalassemia increases the incidence of contracting mild malaria in the first 2 years of life, but severe disease was too uncommon to assess adequately. Therefore, we undertook a prospective case-control study of children with severe malaria on the north coast of Papua New Guinea, where malaria transmission is intense and alpha+-thalassemia affects more than 90% of the population. Compared with normal children, the risk of having severe malaria was 0.40 (95% confidence interval 0.22-0.74) in alpha+-thalassemia homozygotes and 0.66 (0.37-1.20) in heterozygotes. Unexpectedly, the risk of hospital admission with infections other than malaria also was reduced to a similar degree in homozygous (0. 36; 95% confidence interval 0.22-0.60) and heterozygous (0.63; 0. 38-1.07) children. This clinical study demonstrates that a malaria resistance gene protects against disease caused by infections other than malaria. The mechanism of the remarkable protective effect of alpha+-thalassemia against severe childhood disease remains unclear but must encompass the clear interaction between this hemoglobinopathy and both malarial and nonmalarial infections.

PIP: A prospective case-control study conducted on the north coast of Papua New Guinea in 1993-96 investigated the hypothesis that alpha(+)-thalassemia provides a selective advantage against endemic Plasmodium falciparum. In this geographic area, alpha(+)-thalassemia affects more than 90% of the population. 249 children admitted to Madang Hospital with one or more symptoms of severe malaria (severe anemia, coma, hypoglycemia, acidosis, and hyperlactatemia) were paired with 249 randomly selected healthy age- and sex-matched controls. Also enrolled were 233 children with infections other than malaria, primarily respiratory infections, gastroenteritis, and meningitis. Compared with healthy community controls, the risk of severe malaria was 0.40 (95% confidence interval (CI), 0.22-0.74) in alpha(+)-thalassemia homozygotes and 0.66 (95% CI, 0.37-1.20) in heterozygotes. The lowest odds ratios for alpha(+)-thalassemia homozygotes were recorded in the acidosis and hyperlactatemia subgroups--the two complications most predictive of malaria mortality. Unexpectedly, the risk of hospital admission with infections other than malaria was reduced to a similar degree in homozygous (0.36; 95% CI, 0.22-0.60) and heterozygous (0.63; 95% CI, 0.38-1.07) children. Although the relevant mechanism is unknown, these findings confirm a clear interaction between thalassemia hemoglobinopathy and both malarial and other infections. Given its high frequency and protective effect against malaria and some other infections, alpha(+)-thalassemia is likely to have a major impact on child survival in coastal Papua New Guinea.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of study area. Fewer children were recruited from regions distant from the hospital and, therefore, these children have been amalgamated into “North Coast,” “South Coast,” and “Islands.” The total population of each region according to the 1990 National Population Census and gene frequency for α− (± standard error) based on all children recruited in this study were as follows: Islands, 5,157 (0.50 ± 0.077); Madang Town and settlements, 4,346 (0.59 ± 0.019); North Ambenob, 1,477 (0.63 ± 0.026); North Coast, 10,665 (0.60 ± 0.028); South Ambenob, 2,285 (0.73 ± 0.021); South Coast, 17,859 (0.52 ± 0.039), and Transgogol and Gal Utu, 10,515 (0.64 ± 0.010).
Figure 2
Figure 2
Risk of clinical disease compared with community controls according to genotype for α+-thalassemia. Odds ratios with 95% confidence intervals represent the risk for children with α+-thalassemia of developing each of the clinical outcomes relative to normals. Numbers in each group are shown in parentheses. (Inset) Results from the matched index case-community control analysis (Table 1).

References

    1. Weatherall D J, Clegg J B. The Thalassaemia Syndromes. Oxford: Blackwell; 1981.
    1. Flint J, Hill A V S, Bowden D K, Oppenheimer S J, Sill P R, Serjeantson S W, Bana-Koiri J, Bhatia K, Alpers M P, Boyce A J, Weatherall D J, Clegg J B. Nature (London) 1986;321:744–750. - PubMed
    1. Yenchitsomanus P, Summers K M, Board P G, Bhatia K, Jones G L, Johnston K, Nurse G T. Hum Genet. 1986;74:432–437. - PubMed
    1. Terrenato L, Shrestha S, Dixit K A, Luzzatto L, Modiano G, Morpurgo G, Arese P. Ann Trop Med Parasitol. 1988;82:1–11. - PubMed
    1. Modiano G, Morpurgo G, Terrenato L, Novelletto A, Di Rienzo A, Colombo B, Purpura M, Mariani M, Santachiara-Benerecetti S, Brega A, Dixit K A, Shrestha S L, Lania A, Wanachiwanawin W, Luzzatto L. Am J Hum Genet. 1991;48:390–397. - PMC - PubMed

Publication types